Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × alovudine × Clear all

Phase

Status

Completed 24 Terminated 7 Withdrawn 4 Active not recruiting 3 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 454 Radiotherapy 332 Cyclophosphamide 316 Carboplatin 311 Paclitaxel 295 Capecitabine 291 Oxaliplatin 281 Docetaxel 274 Gemcitabine 269 Fluorouracil 245 apatinib 223 Drug Therapy 221 Bevacizumab 203 camrelizumab 185 Etoposide 174 Irinotecan 157 Doxorubicin 154 Leucovorin 133 Dexamethasone 133 Cytarabine 128 Blood Specimen Collection 127 pembrolizumab 122 Neoadjuvant Therapy 119 sintilimab 116 Pemetrexed 115 anlotinib 114 Rituximab 110 toripalimab 109 Surgical Procedures, Operative 109 S 1 (combination) 108

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01713049 2012-10-24

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

National Taiwan University Hospital

Phase NA Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡